23 March 2020 | News
Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.
image courtesy: acnnewswire
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citeline Awards 2020 (formerly CARE Awards), hosted by Informa Pharma Intelligence, scheduled this year on September 17th. The categories are Clinical Research Team of the Year, and Medidata Clinical Partnership of the Year.
Dr John Moller, Novotech CEO, said, "These are major milestones for the company, and further recognition of Novotech as the premier CRO in Asia-Pacific. We are particularly thrilled that the Medidata Clinical Partnership of the Year recognizes Novotech and its Chinese partner PPC, for excellence in clinical trial services in the Asia region."
Karen Currie, Citeline Executive Director of Editorial, said: "We had a highly competitive pool of entries this year. Nominations were received from a variety of organizations, from large and small CROs to young biotechs and well-established pharmas, to specialized vendors who provide indispensable services to the clinical research industry. Attaining a position on a shortlist is a tremendous achievement and we extend our congratulations to all the finalists."
Now in their fifth year, the Citeline Awards honor the accomplishments of those working behind the scenes in Clinical R&D, improving healthcare worldwide through the discovery and development of new drugs. The Citeline Awards focus on the people and companies inspiring the biopharm industry through tireless work, innovative thinking, and advances across Clinical R&D.
Currie said "Drug development is a challenging endeavor, and we are pleased and honored to celebrate the accomplishments of this distinguished group of R&D professionals at the upcoming awards ceremony."